A proteomic study on a human osteosarcoma cell line Saos-2 treated with diallyl trisulfide

Anti-Cancer Drugs

Volumn 20, Issue 8, 2009, Pages 702-712

  Zhang, Yong Kui ^a   Zhang, Xu Hua ^b   Li, Jian Min ^c   Sun, De Sheng ^d   Yang, Qiang ^c   Diao, Dong Mei ^e  

^a University of Traditional Chinese Medicine   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d Peoples Hospital of Penglai City   (United States)

^e Department of Clinical Laboratory   (China)

Author keywords

Apoptosis; Diallyl trisulfide; Osteosarcoma; Proteome

Indexed keywords

DIALLYL TRISULFIDE;

APOPTOSIS; ARTICLE; CANCER RISK; CELL CYCLE ARREST; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GARLIC; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEOMICS; RISK REDUCTION; TWO DIMENSIONAL ELECTROPHORESIS;

ALLYL COMPOUNDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MASS SPECTROMETRY; OSTEOSARCOMA; PROTEINS; PROTEOMICS; SULFIDES; UP-REGULATION;

EID: 70349337157     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32832e89c7     Document Type: Article

References (64)

1. Rivlin RS. Historical perspective on the use of garlic. J Nutr 2001; 131:951s-954s.
2. Manson MM. Cancer prevention-the potential for diet to modulate molecular signaling. Trends Mol Med 2003; 9:11-18.
3. Yu FL, Bender W, Fang Q, Ludeke A, Welch B. Prevention of chemical carcinogen DNA binding and inhibition of nuclear RNA polymerase activity by organosulfur compounds as the possible mechanisms for their anticancer initiation and proliferation effects. Cancer Detect Prev 2003; 27:370-379.
4. Guyonnet D, Belloir C, Suschetet M, Siess MH, Le Bon AM. Mechanisms of protection against aflatoxin B (1) genotoxicity in rats treated by organosulfur compounds from garlic. Carcinogenesis 2002; 23:1335-1341.
5. Hu X, Benson PJ, Srivastava SK, Mack LM, Xia H, Gupta V, et al. Glutathione S-transferases of female A/J mouse liver and forestomach and their differential induction by anticarcinogenic organosulfides from garlic. Arch Biochem Biophys 1996; 336:199-214.
6. Andorfer JH, Tchaikovskaya T, Listowsky I. Selective expression of glutathione S-transferase genes in the murine gastrointestinal tract in response to dietary organosulfur compounds. Carcinogenesis 2004; 25:359-367.
7. Tsai CW, Chen HW, Yang JJ, Sheen LY, Lii CK. Diallyl disulfide and diallyl trisulfide up-regulate the expression of the p class of glutathione S-transferase via an AP-1-dependent pathway. J Agric Food Chem 2007; 55:1019-1026.
8. Xiao D, Herman-Antosiewicz A, Antosiewicz A, Xiao H, Brisson M, Laz JS, et al. DATS-induced cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species dependent destruction and hyperphosphorylation of Cdc25C. Oncogene 2005; 24:6256-6268.
9. Herman-Antosiewicz A, Singh SV. Checkpoint kinase 1 regulates diallyl trisulfide-induced mitotic arrest in human prostate cancer cells. J Biol Chem 2005; 280:28519-28528.
10. Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, et al. DATS-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 2004; 23:5594-5606.
11. Xiao D, Singh SV. Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells. Carcinogenesis 2006; 27:533-540.
12. Herman-Antosiewicz A, Singh SV. Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review. Mutat Res 2004; 555:121-131.
13. Takashi H, Tomomi F, Jun O, Yoshimasa I, Hajime S, Taiichiro S, et al. Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of b-tubulin. J Biol Chem 2005; 280:41487-41493.
14. Li N, Guo R, Li W, Shao J, Li S, Zhao K, et al. A proteomic investigation into a human gastric cancer cell line BGC823 treated with diallyl trisulfide. Carcinogenesis 2006; 27:1222-1231.
15. Kang JH, Park KK, Lee IS, Magae JJ, Ando Kim CH, Chang YC. Proteome analysis of responses to ascochlorin in a human osteosarcoma cell line by 2-D gel electrophoresis and MALDI-TOF MS. J Proteome Res 2006; 5:2620-2631.
16. Posadas EM, Simpkins F, Liotta LA, MacDonald C, Kohn EC. Proteomic analysis for the early detection and rational treatment of cancer-realistic hope? Ann Oncol 2005; 16:16-22.
17. Li ZP, Michael K, Stefan M, Nikica M, Michael OG, Brigitte MP. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death. Proteomics 2006; 6:5735-5745.
18. Spreafico A, Frediani B, Capperucci C, Chellini F, Paffetti A, Ambrosio G, et al. A proteomic study on human osteoblastic cells proliferation and differentiation. Proteomics 2006; 6:3520-3532.
19. Jakubikova J, Sedlak J. Garlic-derived organosulfides induce cytotoxicity, apoptosis, cell cycle arrest and oxidative stress in human colon carcinoma cell lines. Neoplasma 2006; 53:191-199.
20. Wu CC, Chung JG, Tsai SJ, Yang JH, Sheen LY. Differential effects of allyl sulfides from garlic essential oil on cell cycle regulation in human liver tumor cells. Food Chem Toxicol 2004; 42:1937-1947.
21. Zwickl P, Voges D, Baumeister W. The proteasome: a macromolecular assembly designed for controlled proteolysis. Phil Trans R Soc Lond B Biol Sci 1999; 354:1501-1511. (Pubitemid 29464081)
22. Rajkumar SV, Richardson PG, Hideshima T, Anderson KC. Proteasome inhibition as a novel therapeutic target in human cancer. J Clin Oncol 2005; 23:630-639.
23. Codony-Servat J, Tapia MA, Bosch M, Oliva C, Domingo-Domenech J, Mellado B, et al. Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells. Mol Cancer Ther 2006; 5:665-675.
24. Laurent N, Bouard S, Guillamo JS, Christov C, Zini R, Jouault H, et al. Effects of the proteasome inhibitor ritonavir on glioma growth in vitro and in vivo. Mol Cancer Ther 2004; 3:129-136.
25. Bazzaro M, Lee MK, Zoso A, Wanda HS, Santillan A, Shih IM, et al. Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis. Cancer Res 2006; 66:3754-3763.
26. Paramio JM, Casanova ML, Segrelles C, Mittnacht S, Lane EB, Jorcano JL. Modulation of cell proliferation by cytokeratins k10 and k16. Mol Cell Biol 1999; 19:3086-3094.
27. Paramio JM, Segrelles C, Ruiz S, Jorcano JL. Inhibition of protein Kinase B (PKB) and PKCB mediates keratin K10-induced cell cycle arrest. Mol Cell Biol 2001; 21:7449-7459.
28. Paramio JM, Jorcano JL. Role of protein kinases in the in vitro differentiation of human epidermal HaCaT cells. Br J Dermatol 1997; 137:44-50.
29. Xiao D, Lew KL, Kim YA, Zeng Y, Hahm ER, Dhir R, et al. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction. Clin Cancer Res 2006; 12:6836-6843.
30. Lee AS. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 2007; 67:3496-3499.
31. Song MS, Park YK, Lee JH, Park K. Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-e/ERK/AP-1 signaling cascade. Cancer Res 2001; 61:8322-8330.
32. Ermakova SP, Kang BS, Choi BY, Choi HS, Schuster TF, Ma WY, et al. (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res 2006; 66:9260-9269.
33. Davidson DJ, Haskell C, Majest S, Kherzai A, Egan DA, Walter KA, et al. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78. Cancer Res 2005; 65:4663-4672.
34. Ranganathan AC, Zhang L, Adam AP, Aguirre-Ghiso JA. Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res 2006; 66:1702-1711.
35. Gonzalez-Gronow M, Cuchacovich M, Llanos C, Urzua C, Gawdi G, Pizzo SV. Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum. Cancer Res 2006; 66:11424-11431.
36. Gupta P, Walter MR, Su ZZ, Lebedeva IV, Emdad L, Randolph A, et al. BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis. Cancer Res 2006; 66:8182-8191.
37. Bagatell R, Whitesell L. Altered Hsp90 function in cancer: A unique therapeutic opportunity. Mol Cancer 2004; 3:1021-1030.
38. Beere HM, Wolf BB, Cain K. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2000; 2:469-475.
39. Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2000; 2:476-483.
40. Rao JY, Li N. Microfilament actin remodeling as potential target for cancer drug development. Curr Cancer Drug Targets 2004; 4:345-354.
41. Verrills NM, Pouha ST, Liu ML, Liaw TY, Larsen MR, Ivery MT, et al. Alterations in g-actin and tubulin-targeted drug resistance in childhood leukemia. J Natl Cancer Inst 2006; 98:1363-1374.
42. Hattori M, Minato N. Rap1 GTPase: functions, regulation, and malignancy. J Biochem 2003; 134:479-484.
43. Gao L, Feng Y, Bowers R, Becker-Hapak M, Gardner J, Council L, et al. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis. Cancer Res 2006; 66:7880-7888.
44. Itoh M, Nelson CM, Myers CA, Bissell MJ. Rap1 integrates tissue polarity, lumen formation, and tumorigenic potential in human breast epithelial cells. Cancer Res 2007; 7:4759-4766.
45. De Falco V, Castellone MD, De Vita G, Cirafici AM, Hershman JM, Guerrero C, et al. RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. Cancer Res 2007; 67:381-390.
46. Park EK, Kwon KB, Park KI, Park BH, Jhee EC. Role of Ca(2+) in diallyl disulfide-induced apoptosis cell death of HCT-15 cells. Exp Mol Med 2002; 34:250-257.
47. Sakamoto K, Lawson LD, Milner JA. Allyl sulfides from garlic suppress the in vitro proliferation of human A549 lung tumor cells. Nutr Cancer 1997; 29:152-156.
48. Lee AS. Mammalian stress response: induction of the glucose-regulated protein family. Curr Opin Cell Biol 1992; 4:267-273.
49. Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M. Calreticulin: one protein, one gene, many functions. J Biochem 1999; 344:281-292.
50. Arnaudeau S, Frieden M, Nakamura K, Castelbou C, Michalak M, Demaurex N. Calreticulin differentially modulates calcium uptake and release in the endoplasmic reticulum and mitochondria. J Biol Chem 2002; 277:46696-46705.
51. Kageyama K, Ihara Y, Goto S, Urata Y, Toda G, Yano K, et al. Overexpression of calreticulin modulates protein kinase B/Akt signaling to promote apoptosis during cardiac differentiation of cardiomyoblast H9c2 cells. J Biol Chem 2002; 277:19255-19264.
52. Okunaga T, Urata Y, Goto S, Matsuo T, Mizota S, Tsutsumi K, et al. Calreticulin, a molecular chaperone in the endoplasmic reticulum, modulates radiosensitivity of human glioblastoma U251MG cells. Cancer Res 2006; 66:8662-8671.
53. Mesaeli N, Phillipson C. Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells. Mol Biol Cell 2004; 15:1862-1870.
54. Yoon WH, Song IS, Lee BH, Jung YJ, Kim TD, Li G, et al. Differential regulation of vimentin mRNA by 12-O-tetradecanoylphorbol 13-acetate and all-trans-retinoic acid correlates with motility of Hep 3B human hepatocellular carcinoma cells. Cancer Lett 2004; 203:99-105.
55. Wu M, Bai X, Xu G, Wei J, Zhu T, Zhang Y, et al. Proteome analysis of human androgen-independent prostate cancer cell lines: variable metastatic potentials correlated with vimentin expression. Proteomics 2007; 7:1973-1983.
56. Byun Y, Chen F, Chang R, Trivedi M, Green KJ, Cryns VL. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ 2001; 8:443-450.
57. Singh S, Sadacharan S, Su S, Belldegrun A, Persad S, Singh G. Overexpression of vimentin: role in the invasive phenotype in an androgen independent model of prostate cancer. Cancer Res 2003; 63:2306-2311.
58. Kaya B, Mena H, Miettinen M, Rushing EJ. Alpha-internexin expression in medulloblastomas and atypical teratoid-rhabdoid tumors. Clin Neuropathol 2003; 22:215-221.
59. Chien CL, Liu TC, Ho CL, Lu KS. Overexpression of neuronal intermediate filament protein a-internexin in PC12 cells. J Neurosci Res 2005; 80:693-706.
60. Manara MC, Baldini N, Serra M, Lollini PL, De Giovanni C, Vaccari M, et al. Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase gene. Bone 2000; 26:215-220.
61. Orimot H, Shimada T. Regulation of the human tissue-nonspecific alkaline phosphatase gene expression by all-trans-retinoic acid in SaOS-2 osteosarcoma cell line. Bone 2005; 36:866-876.
62. Tsai LC, Hung MW, Chen YH, Su WC, Chang GG, Chang TC. Expression and regulation of alkaline phosphatases in human breast cancer MCF-7 cells. Eur J Biochem 2000; 267:1330-1333.
63. Namba T, Hoshino T, Tanaka K, Tsutsumi S, Ishihara T, Mima S, et al. Up-regulation of 150-kDa oxygen-regulated protein by celecoxib in human gastric carcinoma cells. Mol Pharmacol 2007; 71:860-870.
64. Harada T, Harada C, Wang YL, Osaka H, Amanai K, Tanaka K, et al. Role of ubiquitin carboxy terminal hydrolase-l1 in neural cell apoptosis induced by ischemic retinal injury in vivo. Am J Pathol 2004; 164:59-64.